|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPH0665280B2
(ja)
|
1987-03-04 |
1994-08-24 |
味の素株式会社 |
タンパクゲル化剤及びそれを用いるタンパクのゲル化方法
|
|
DE4022267C2
(de)
|
1990-07-12 |
1994-09-15 |
Degussa |
N-Acyldipeptide und deren Verwendung
|
|
JP2849773B2
(ja)
|
1990-08-27 |
1999-01-27 |
天野製薬株式会社 |
ストレプトミセス属由来のトランスグルタミナーゼの製造法
|
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
CA2142981C
(en)
|
1992-08-31 |
2007-10-23 |
Joseph Y. Tai |
Vaccines against group c neisseria meningitidis
|
|
US5425946A
(en)
|
1992-08-31 |
1995-06-20 |
North American Vaccine, Inc. |
Vaccines against group C Neisseria meningitidis
|
|
US5508191A
(en)
|
1993-07-05 |
1996-04-16 |
Takeda Chemical Industries, Ltd. |
Mutant strains of agrobacterium for producing β-1,3-glucan
|
|
EP0777726B1
(en)
|
1994-08-26 |
2006-06-07 |
Novozymes A/S |
Microbial transglutaminases, their production and use
|
|
EP0785276A4
(en)
|
1994-09-29 |
2002-01-09 |
Ajinomoto Kk |
MODIFICATION OF A PEPTIDE AND A PROTEIN
|
|
ATE248219T1
(de)
|
1995-01-19 |
2003-09-15 |
Novozymes As |
Transglutaminasen aus oomyzeten
|
|
JP3669390B2
(ja)
|
1995-02-09 |
2005-07-06 |
味の素株式会社 |
バチルス属細菌由来のトランスグルタミナーゼ
|
|
US6284884B1
(en)
|
1995-06-07 |
2001-09-04 |
North American Vaccine, Inc. |
Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
|
|
EP0815833B1
(en)
|
1996-06-24 |
2003-04-09 |
Givaudan SA |
Malodour preventing agents
|
|
US6620916B1
(en)
|
1996-09-26 |
2003-09-16 |
Ajinomoto Co., Inc. |
Modified physiologically active proteins and medicinal compositions containing the same
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
JP3981525B2
(ja)
|
1998-01-20 |
2007-09-26 |
ハワード・グリーン |
組織への物質のトランスグルタミナーゼ連結
|
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
CA2435681C
(en)
|
2001-01-23 |
2011-06-21 |
Aventis Pasteur |
Multivalent meningococcal polysaccharide-protein conjugate vaccine
|
|
US7605175B2
(en)
|
2001-03-02 |
2009-10-20 |
Gpc Biotech Ag |
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
JP2003199569A
(ja)
|
2001-12-17 |
2003-07-15 |
Food Industry Research & Development Inst |
ストレプトベルティシリウム・ラダカヌムのトランスグルタミナーゼ遺伝子及び該遺伝子によってコードされるトランスグルタミナーゼ
|
|
ES2616180T3
(es)
|
2002-03-26 |
2017-06-09 |
Glaxosmithkline Biologicals Sa |
Sacáridos modificados con estabilidad mejorada en agua para su uso como medicamento
|
|
GB0211118D0
(en)
|
2002-05-15 |
2002-06-26 |
Polonelli Luciano |
Vaccines
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
WO2006028129A1
(ja)
|
2004-09-10 |
2006-03-16 |
Toray Industries, Inc. |
医薬品製剤
|
|
MX2007005202A
(es)
|
2004-11-01 |
2007-07-09 |
Brigham & Womens Hospital |
Polisacaridos de estreptococo modificados y usos de los mismos.
|
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
|
BRPI0611570A2
(pt)
*
|
2005-06-15 |
2011-02-22 |
Novo Nordisk Healthcare Ag |
métodos para fixar covalentemente peg a um polipeptìdeo e para modificar propriedades farmacológicas de hormÈnio de crescimento, composto e sais, pró-drogas ou solvatos farmaceuticamente aceitáveis do mesmo, hormÈnio de crescimento humano, composição farmacêutica, método para tratamento de doença e, uso de um composto
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
JP5703020B2
(ja)
*
|
2007-08-24 |
2015-04-15 |
ノボ ノルディスク ヘルス ケア アーゲー |
タンパク質を選択的に修飾するための組成物と方法
|
|
US8426179B2
(en)
*
|
2007-08-30 |
2013-04-23 |
Northwestern University |
Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme
|
|
DE102007044296A1
(de)
*
|
2007-09-17 |
2009-03-19 |
Hans-Lothar Prof. Dr. Fuchsbauer |
Strukturmodulator von Proteinen
|
|
US8137925B2
(en)
*
|
2007-11-09 |
2012-03-20 |
Massachusetts Institute Of Technology |
Methods and compositions for protein labeling using lipoic acid ligases
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
US20110184147A1
(en)
*
|
2008-07-04 |
2011-07-28 |
Kyushu University, National University Corporation |
Enzyme substrate for labeling of protein
|
|
US20110306551A1
(en)
*
|
2009-02-19 |
2011-12-15 |
Novo Nordisk A/S |
Modification of Factor VIII
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
US8853151B2
(en)
|
2009-06-30 |
2014-10-07 |
The Regents Of The University Of Michigan |
Pro-drug complexes and related methods of use
|
|
US20110020837A1
(en)
|
2009-07-07 |
2011-01-27 |
Universiteit Utrecht Holding B.V. |
Method for isolating or identifying a target protein interacting with a lipid in a cell
|
|
EP2515914A4
(en)
|
2009-12-23 |
2013-09-11 |
Scripps Research Inst |
BIOCONJUGATION OF TYROSINE BY EYE REACTIONS IN AQUEOUS MEDIA
|
|
US8859629B2
(en)
*
|
2010-04-27 |
2014-10-14 |
Synaffix B.V. |
Fused cyclooctyne compounds and their use in metal-free click reactions
|
|
EP2591354B1
(en)
|
2010-07-07 |
2016-09-07 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
US20130178609A1
(en)
|
2010-07-09 |
2013-07-11 |
Centre National De La Recherche Scientifique - Cnrs |
Modular construction of lipophospholipids
|
|
CN103298949A
(zh)
|
2010-10-29 |
2013-09-11 |
生命科技公司 |
生物素衍生物
|
|
CA2813411C
(en)
|
2010-11-05 |
2016-08-02 |
Rinat Neuroscience Corporation |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
EP2649099A4
(en)
|
2010-12-07 |
2016-10-19 |
Univ Yale |
SMALL MOLECULAR HYDROPHOBIC LABELING OF FUSION PROTEINS AND INDUCED REMOVAL FROM THIS
|
|
EP2651411B1
(en)
|
2010-12-13 |
2020-09-16 |
Immunomedics, Inc. |
Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
|
|
WO2012142659A1
(en)
|
2011-04-19 |
2012-10-26 |
Baker Idi Heart And Diabetes Institute Holdings Limited |
Site-selective modification of proteins
|
|
FR2981352B1
(fr)
|
2011-10-17 |
2015-07-03 |
Centre Nat Rech Scient |
Procede de synthese de proteines
|
|
CN104145015A
(zh)
*
|
2011-12-01 |
2014-11-12 |
安吉奥开米公司 |
靶向的溶酶体酶化合物
|
|
JP5509440B2
(ja)
*
|
2012-06-22 |
2014-06-04 |
国立大学法人九州大学 |
タンパク質−核酸複合体の製造方法および標的物の検出方法
|
|
KR20160042871A
(ko)
*
|
2013-06-21 |
2016-04-20 |
이나뜨 파르마, 에스.아. |
폴리펩티드의 효소적 콘쥬게이션
|
|
KR20160040556A
(ko)
*
|
2013-07-11 |
2016-04-14 |
노파르티스 아게 |
미생물 트랜스글루타미나제를 사용한 리신-특이적 화학효소적 단백질 변형
|